Cardinal Health Inc. ($CAH) Stock Forecast: Down 4.5% Today

What is Cardinal Health Inc.?

Cardinal Health (CAH) is a healthcare services company that has been performing well in the market, with analysts maintaining a "Strong Buy" rating and anticipating significant profit growth.

Why is Cardinal Health Inc. going down?

CAH stock is down 4.5% on Apr 22, 2026 16:06

• Cardinal Health (CAH) stock experienced a significant bearish movement, falling by 2.96%.
• Despite analysts' positive expectations for the earnings report, the market reacted negatively to the stock.
• The underperformance of CAH compared to competitors and broader market indices suggests that investors may have had higher expectations for the company's performance.
• The upcoming earnings report will be crucial in determining if the stock can regain its momentum and reverse the bearish trend.

CAH Price Chart

CAH Technical Analysis

CAH News

Earnings Preview: What to Expect From Cardinal Health's Report

Cardinal Health (CAH) is set to announce its fiscal Q3 2026 earnings before market open on April 30. Analysts anticipate a 19.6% increase in profit to $2.81 per share, continuing a trend of exceeding Wall Street's bottom-line estimates. The healthcare services company has seen significant stock appreciation, outperforming the S&P 500 and a healthcare ETF over the past year, and analysts maintain a "Strong Buy" rating with a substantial potential upside.

https://www.barchart.com/story/news/1443629/earnings-preview-what-to-expect-from-cardinal-health-s-report

Assessing McKesson (MCK) Valuation After Robust Results And Strong Buybacks Attract Investor Interest

McKesson (MCK) has shown robust financial results with strong sales growth, faster earnings expansion, and ongoing share buybacks, driven by its significant presence in healthcare distribution. Despite recent short-term share price fluctuations, the company has delivered substantial long-term returns. Analysts suggest McKesson is currently undervalued, with a fair value target implying a significant upside, though risks like tighter drug price regulation exist.

https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/assessing-mckesson-mck-valuation-after-robust-results-and-st

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

Cardinal Health (CAH) stock experienced a 2.96% drop, exceeding the broader market's decline, despite a 2.32% gain over the past month. The company is set to release its earnings report on April 30, 2026, with analysts forecasting significant EPS and revenue growth. Cardinal Health currently holds a Zacks Rank #2 (Buy) and its valuation metrics suggest it trades at a premium compared to its industry average.

https://sg.finance.yahoo.com/news/cardinal-health-cah-registers-bigger-221503012.html

Cardinal Health Inc. stock underperforms Tuesday when compared to competitors

Cardinal Health Inc. (CAH) shares fell by 2.96% on Tuesday, closing at $204.92. This underperformance occurred during a generally poor trading session for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. This marks the second consecutive day of losses for Cardinal Health stock.

https://www.marketwatch.com/data-news/cardinal-health-inc-stock-underperforms-tuesday-when-compared-to-competitors-7f79e003-5b71e83407ff

CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing

CareDx has launched AlloSeq Nano, a nanopore-based solution for high-resolution HLA and ABO genotyping, at the European Federation for Immunogenetics (EFI) Conference 2026. This new technology promises rapid and accurate results within three hours, with minimal hands-on time, and is expected to enhance CareDx's position in transplant diagnostics. The company also announced plans to divest its Lab Products business and recently launched VANTx, an AI-driven clinical data platform.

https://www.tradingview.com/news/zacks:e9b29f8f1094b:0-caredx-launches-alloseq-nano-for-high-resolution-rapid-hla-typing/

Trending Today

Tilray Inc. ($TLRY) Stock Forecast: Down 5.3% Today

Incyte Corporation ($INCY) Stock Forecast: Up 1.3% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 7.3% Today

United Parcel Service Inc. ($UPS) Stock Forecast: Down 4.9% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.2% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.1% Today

Universal Health Services Inc. ($UHS) Stock Forecast: Down 6.9% Today

Albemarle Corporation ($ALB) Stock Forecast: Down 5.1% Today

Packaging Corporation of America ($PKG) Stock Forecast: Up 3.1% Today

Cardinal Health Inc. Price History

22.03.2026 - CAH Stock was down 4.5%

• Cardinal Health (CAH) stock experienced a significant bearish movement, falling by 2.96%.
• Despite analysts' positive expectations for the earnings report, the market reacted negatively to the stock.
• The underperformance of CAH compared to competitors and broader market indices suggests that investors may have had higher expectations for the company's performance.
• The upcoming earnings report will be crucial in determining if the stock can regain its momentum and reverse the bearish trend.

05.00.2026 - CAH Stock was up 1.0%

• The strategic shift towards specialty pharmaceutical distribution and healthcare services by Cardinal Health is positively impacting its growth trajectory.
• The overall bullish sentiment in the pharmaceutical industry, as evidenced by the projected growth of the Palliative Care Market, is likely contributing to CAH's upward movement.
• Analysts lowering price targets for competitors like Cencora (COR) while maintaining a Neutral rating may be diverting investor attention towards Cardinal Health, driving its stock price higher.
• The recognition of Cardinal Health as a stable long-term investment due to its essential role in the healthcare supply chain and consistent demand for medications is attracting investors seeking steady growth opportunities.

02.11.2025 - CAH Stock was down 3.0%

• The bearish movement in Cardinal Health's stock today could be attributed to various factors:
• Despite the company's increased operating earnings, the recent revenue dip might have raised concerns among investors about its growth prospects.
• The acquisition announcement and year-end results reporting might have not met market expectations, leading to a negative sentiment towards the stock.
• The overall market sentiment towards healthcare stocks or specific developments within the healthcare sector could have influenced the bearish movement in CAH's stock price.
• Investors might be reevaluating Cardinal Health's financial stability and growth potential in comparison to other highlighted stocks with strong interest coverage ratios.
• The focus on financial metrics like the Price-to-Earnings ratio and valuation scores in discussions about other companies could have also shifted investor attention away from Cardinal Health, impacting its stock performance negatively.

13.00.2026 - CAH Stock was up 5.2%

• Following an upward trend, Cardinal Health's stock witnessed a surge subsequent to the company's revision of its fiscal-year guidance and its forecast of specialty revenue surpassing $50 billion for 2026.
• The optimistic projections for 2026, fueled by successful strategic moves like alterations in Medicare Drug Prices and alliances with Publix Super Markets, played a significant role in driving the stock's upward trajectory.
• Launches such as the ContinuCare™ Pathway program for diabetes supply management, coupled with strong performance across operational sectors, underscored the company's substantial strategic advancement.
• In essence, Cardinal Health's favorable forecasts and strategic endeavors have bolstered investors' confidence, thereby propelling the bullish trend in the stock market.

08.00.2026 - CAH Stock was down 3.0%

• The recent decline in CAH stock price could be linked to profit-taking by investors following a previous increase in value.
• Although Cardinal Health delivered impressive Q3 earnings that exceeded analyst expectations, market sentiment or profit-related concerns may have driven the stock lower.
• An increased investment by Robeco Institutional Asset Management B.V. initially inspired confidence in the stock, but prevailing market conditions may have overshadowed this development.
• Investor focus on the strong performance and growth potential of McKesson in the healthcare sector may have diverted attention from Cardinal Health, impacting its stock performance unfavorably.

05.01.2026 - CAH Stock was up 7.7%

• CAH surpassed analyst projections in its second-quarter earnings, leading to a rise in its stock value.
• The company adjusted its full-year earnings forecast upward for the second time, showing strong confidence in its future business performance.
• The robust results and achievement of a new 52-week high were driven by the strong performance in its Pharmaceutical and Specialty Solutions division.
• Investor sentiment towards CAH is optimistic, as analysts hold a consensus "Strong Buy" rating with potential for increased gains, reflecting confidence in the company's future growth.

05.01.2026 - CAH Stock was up 7.3%

• Today, Cardinal Health (CAH) witnessed a notable uptrend following the announcement of exceptional Q4 CY2025 results that outperformed market predictions.
• The company's strong financial showing was fueled by a substantial increase in revenue, surpassing analyst forecasts by a significant margin.
• Cardinal Health adjusted its full-year EPS guidance upwards, indicating optimism in its strategic efforts and the strong industry momentum in healthcare distribution.
• The upsurge in demand for specialty drugs and the company's foray into high-profit markets were key drivers in the positive outlook and the heightened profitability projections, further instilling investor confidence in Cardinal Health's future prospects.

05.01.2026 - CAH Stock was up 9.4%

• Cardinal Health's robust growth momentum, driven by strong utilization and successful acquisitions, has led to an impressive earnings report that surpassed analyst expectations.
• The company's consistent guidance hikes and increased fiscal-year earnings guidance have instilled confidence in investors, resulting in a surge in the stock price.
• Cardinal Health's focus on strategic initiatives and solid financial performance, including a significant increase in sales and adjusted earnings, has propelled the stock to reach a new 52-week high.
• The positive market sentiment towards Cardinal Health is further fueled by the CEO's explanation of the factors contributing to the company's success, reinforcing investor optimism in the stock's future prospects.

12.01.2026 - CAH Stock was down 3.8%

• Cardinal Health (CAH) faced a downwards trend in the market today amid mixed earnings reports in the healthcare sector.
• Despite positive Q4 results and an increased annual outlook, concerns emerged during the earnings call regarding profit distribution, capital management, and the effects of market price adjustments.
• A general sense of caution in the healthcare industry, exemplified by other companies like Baxter International and QuidelOrtho, may have influenced the negative response to Cardinal Health's performance.
• Investors appear to be reassessing their healthcare investments, resulting in a decline in CAH shares, despite the company's strong financial standing.

04.01.2026 - CAH Stock was down 5.0%

• Cardinal Health revised its FY25 earnings forecast upwards, anticipating notable growth in EPS over the next three years, which should typically have a positive effect on the stock.
• Allianz Asset Management GmbH decreased its ownership in Cardinal Health by 30%, potentially indicating investor uncertainty or profit-taking, which could have contributed to the recent market decline.
• Despite the encouraging earnings forecast and solid segment performance, the market's response towards Cardinal Health appears to have been more influenced by the significant reduction in ownership by a major investor, leading to the recent downturn.
• Various factors such as the overall healthcare sector's performance and general market trends may have also impacted the recent bearish movement of Cardinal Health's stock.

30.09.2025 - CAH Stock was up 17.4%

• Cardinal Health (CAH) experienced a strong bullish movement today, with its stock price increasing by +1.72%.
• The positive market movement can be attributed to the expectation of double-digit revenue growth in Q1 FY26, primarily driven by the Pharmaceutical and Specialty units.
• Additionally, the company's consistent outperformance in the market over the past 5 years, with an average annual return of 27.8%, has likely contributed to investor confidence and buying interest in CAH shares.
• Overall, the market seems optimistic about Cardinal Health's future prospects, supported by strong financial performance and growth potential in key business segments.

30.09.2025 - CAH Stock was up 13.0%

• The stock of Cardinal Health saw a notable increase following the positive announcement of its first-quarter 2026 earnings. Adjusted earnings outperformed expectations, and sales witnessed a substantial year-over-year growth.
• Cardinal Health's successful performance in Q1 and the upgraded 2026 EPS forecast point towards a widespread expansion and growing profitability across all sectors, fostering investor confidence.
• Investor optimism towards Cardinal Health has been influenced by its consistent market outperformance in the last 5 years, indicating attractive returns for stakeholders.
• Anticipated double-digit revenue growth in the first quarter of fiscal year 2026, especially in the Pharmaceutical and Specialty units, has further heightened investor confidence in the company's future prospects, encouraging a bullish trend in the stock price.